欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

墨西哥制药和医疗保健行业报告(2019-2020年)

Mexico Pharma and Healthcare Sector Report 2019-2020

加工时间:2019-03-22 信息来源:EMIS 索取原文[73 页]
关键词:制药;医疗保健行业;竞争程度;细分市场而异;高度竞争;制药;零售业;药品零售额
摘 要:

The level of competition in the pharma and healthcare sector varies across segments. A relatively high degree of competition is observed in the pharmaceutical manufacturing, with 795 active companies as of March 2018, of which 13% large enterprises with more than 250 employees. On the other hand, as of the same month, there were 93,313 pharmacies in Mexico. Yet, the pharmaceutical retail exhibits a moderate degree of competition, as five medium-sized chains accounted for 54.4% of the drug retail sales in 2017. The health insurance in Mexico is virtually monopolised by the government, with only a small private health insurance system offering some choice for consumers.


目 录:

01 EXECUTIVE SUMMARY 

02 SECTOR IN FOCUS 

03 COMPETITIVE LANDSCAPE 

04 COMPANIES IN FOCUS

05 REGULATORY ENVIRONMENT 

06 PHARMACEUTICALS 

07 HEALTHCARE 

08 RETAIL CHANNELS


© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服